-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
although regulations are sometimes seen as less pleasant elements in product development, they can create or destroy an ingredient, a product, or even an entire industry. Operating within U.S. regulations will be challenging for innovative new ingredients. And when companies operate in multiple countries, the challenge grows exponentially.consequences of failing to determine whether all ingredients for a food comply with local regulations can be severe.
product will be detained by customs or may need to be destroyed,
said
Carolyn Fisher, a senior scientist at
International Regulatory Database
Decernis
."
is currently a slow and steady trend towards regional harmonization of regulations, such as the European Union, mercos far south and the Eurasian Economic Union formed by Belarus, Kazakhstan and Russia. However, understanding what is needed is time-consuming and
,"
she added. Regulations come in many different forms and languages and are very difficult to interpret.Fisher
that while probiotics are naturally present in many foods, they must also be safe before they are added to food or beverages. The species of the organism and the metabolic by-products in the food substate must be known. In addition, if a health claim is made, the efficacy proves necessary.recent years, a company that makes news with its innovative probiotics has learned to successfully navigate international regulation.
Ganeden Biotech
reports that its
GanedenBC30
has been approved by regulators in more than
60,
countries on six continents, and more countries are expected to support it in the coming year.
Mike Bush, senior vice president of
ganeden
, who agrees with Fisher
's comments, noted that each country has its own regulatory guidelines. Approval of one ingredient requires significant investment, with some likely to be available within weeks and others years.GanedenBC30
the help of the
P
monograph,
Bush
explained.In other countries, the general process of approving probiotics is to first require us to submit security data and the
FDA
non-objection letter we received as a result of our self-affirming
GRAS
decision.
"
then submitted to the American Pharmacopeia monograph.
"
usually enough for us to get approval, "
added.health claims have become more challenging. The European Food Safety
(EFSA
) rejected hundreds of probiotic health claims that had been submitted. Some countries do not even allow the use
term
"probiotic
"
because it means health benefits.
EFSA
allows healthy claims per serving of at least
⁸CFU
live microorganisms such as the Bulgarian subsetres of Despass and Streptococcusyogurt
/
fermented milk products designed for people with lactose indigestion.DuPont recently made a big move into the non-EU country of Switzerland, as it announced its claim to
Howaru
milk Bifidobacteria
HN019
. Through its work at a large Swiss grocery chain, the National Office of Food Safety and Veterinary Medicine (
FSVO
) will allow statements about probiotics supporting digestion by reducing the amount of time food passes through the intestines.other countries, including Canada and Japan, have issued claims related to licensed probiotics. In Japan, claims are product-based
specific claims
FOSHU systems. The United States has not yet released its list of approved claims.much of the discussion revolves around whether claims about general probiotics are reasonable or whether they are strain-specific.
June
, the International Association for Science Probiotics and Probiotics International Scientific Association published a consensus statement using the termprobiotics
"
(3l
) and comments on regulatory and probiotic health claims regarding the use of the term.statement suggests that specific health benefits may be prevalent in the probiotics studied. Such benefits include, for example
the
normalization of "perturbation microorganisms
"
the production of acids and short-chain fatty acids. Other benefits may often be observed in the most probiotic strains, such as vitamin synthesis and
"
of carcinogens.
"
, there may be more rare benefits, such as immunology, neurology, and endocrine effects, which are specific strains.probiotic microorganisms become increasingly important in healthy lifestyles and disease responses. Regulating their use and claims will be intermittent.